| John M Swirczek, MD | |
|
430 N Monte Vista St, Ada, OK 74820-4610 | |
| (580) 272-0485 | |
| (580) 332-5750 |
| Full Name | John M Swirczek |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 30 Years |
| Location | 430 N Monte Vista St, Ada, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669461372 | NPI | - | NPPES |
| 1578703252 | Medicaid | MI | |
| MI1878012 | Other | MI | MEDICARE ID - TYPE UNSPECIFIED |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35593 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health Hackley Campus | Muskegon, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Marys Health Services | 4981500436 | 163 |
News Archive
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
Today's summit on the future of health care in this country, while far from resolving all of the differences between Republicans and Democrats on reforming our broken health insurance system, was a huge win for the American people.
AXIOM Systems, Inc., today announced the general release of its HIPAA 5010 compliant version of TransSend, a software application developed specifically for healthcare organizations engaged in HIPAA EDI commerce.
A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.
› Verified 9 days ago
| Entity Name | American Anesthesiology Of Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487609475 PECOS PAC ID: 5294648804 Enrollment ID: O20031110000617 |
News Archive
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
Today's summit on the future of health care in this country, while far from resolving all of the differences between Republicans and Democrats on reforming our broken health insurance system, was a huge win for the American people.
AXIOM Systems, Inc., today announced the general release of its HIPAA 5010 compliant version of TransSend, a software application developed specifically for healthcare organizations engaged in HIPAA EDI commerce.
A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.
› Verified 9 days ago
| Entity Name | Saint Marys Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124063078 PECOS PAC ID: 4981500436 Enrollment ID: O20040329001233 |
News Archive
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
Today's summit on the future of health care in this country, while far from resolving all of the differences between Republicans and Democrats on reforming our broken health insurance system, was a huge win for the American people.
AXIOM Systems, Inc., today announced the general release of its HIPAA 5010 compliant version of TransSend, a software application developed specifically for healthcare organizations engaged in HIPAA EDI commerce.
A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.
› Verified 9 days ago
| Entity Name | American Anesthesiology Group Of Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245708403 PECOS PAC ID: 7416296041 Enrollment ID: O20190226003245 |
News Archive
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
Today's summit on the future of health care in this country, while far from resolving all of the differences between Republicans and Democrats on reforming our broken health insurance system, was a huge win for the American people.
AXIOM Systems, Inc., today announced the general release of its HIPAA 5010 compliant version of TransSend, a software application developed specifically for healthcare organizations engaged in HIPAA EDI commerce.
A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John M Swirczek, MD 100 Mcdougal Dr, Holdenville, OK 74848-2822 Ph: (405) 379-4200 | John M Swirczek, MD 430 N Monte Vista St, Ada, OK 74820-4610 Ph: (580) 272-0485 |
News Archive
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
Today's summit on the future of health care in this country, while far from resolving all of the differences between Republicans and Democrats on reforming our broken health insurance system, was a huge win for the American people.
AXIOM Systems, Inc., today announced the general release of its HIPAA 5010 compliant version of TransSend, a software application developed specifically for healthcare organizations engaged in HIPAA EDI commerce.
A drug candidate developed by researchers at the NIH's National Center for Advancing Translational Sciences and its collaborators to treat sickle cell disease has been acquired by Baxter International's BioScience business.
› Verified 9 days ago
Jamie C Koch, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 430 N Monte Vista St, Ok, Ada, OK 74820 Phone: 580-421-1160 Fax: 580-332-5750 | |
Dr. Daniel Rivera, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 430 N Monte Vista St, Ada, OK 74820 Phone: 316-775-8404 | |
Kalen Rogers, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1921 Stonecipher Blvd, Ada, OK 74820 Phone: 580-310-6465 | |
William J Baker, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 430 N Monte Vista St, Ada, OK 74820 Phone: 580-332-2323 Fax: 580-421-6100 | |
Troy Caldwell, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1001 N Country Club Rd, Ada, OK 74820 Phone: 580-421-4570 Fax: 580-421-6283 | |
Dr. Ladny Jerad Yates, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1921 Stonecipher Blvd, Ada, OK 74820 Phone: 580-421-4570 |